Steven H. Olson

3.6k total citations
47 papers, 1.7k citations indexed

About

Steven H. Olson is a scholar working on Molecular Biology, Organic Chemistry and Neurology. According to data from OpenAlex, Steven H. Olson has authored 47 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Organic Chemistry and 10 papers in Neurology. Recurrent topics in Steven H. Olson's work include Neurological diseases and metabolism (10 papers), Prion Diseases and Protein Misfolding (8 papers) and Parkinson's Disease Mechanisms and Treatments (7 papers). Steven H. Olson is often cited by papers focused on Neurological diseases and metabolism (10 papers), Prion Diseases and Protein Misfolding (8 papers) and Parkinson's Disease Mechanisms and Treatments (7 papers). Steven H. Olson collaborates with scholars based in United States, Japan and United Kingdom. Steven H. Olson's co-authors include Stanley B. Prusiner, Samuel J. Danishefsky, Amanda L. Woerman, Sabeen A. Kazmi, Gail G. Hammond, Serge H. Boyer, Paula M.D. Fitzgerald, Jeffrey H. Toney, James M. Balkovec and Smita S. Patel and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Steven H. Olson

43 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven H. Olson United States 24 669 545 271 252 246 47 1.7k
Fengtian Xue United States 27 738 1.1× 595 1.1× 47 0.2× 312 1.2× 163 0.7× 90 1.9k
Stefania Girotto Italy 20 585 0.9× 106 0.2× 72 0.3× 204 0.8× 502 2.0× 41 1.4k
Chul‐Hak Yang South Korea 20 732 1.1× 84 0.2× 107 0.4× 212 0.8× 290 1.2× 35 1.4k
Маргарита Е. Неганова Russia 20 708 1.1× 290 0.5× 26 0.1× 119 0.5× 92 0.4× 103 1.4k
Yuepiao Cai China 25 827 1.2× 351 0.6× 249 0.9× 79 0.3× 11 0.0× 66 1.7k
W. Stephen Faraci United States 18 752 1.1× 275 0.5× 150 0.6× 109 0.4× 23 0.1× 25 1.3k
Arie Gruzman Israel 21 706 1.1× 158 0.3× 15 0.1× 278 1.1× 224 0.9× 73 1.5k
Gyan Modi India 21 472 0.7× 202 0.4× 19 0.1× 283 1.1× 91 0.4× 47 1.2k
Wolfram Hänsel Germany 15 859 1.3× 390 0.7× 60 0.2× 166 0.7× 16 0.1× 45 1.5k

Countries citing papers authored by Steven H. Olson

Since Specialization
Citations

This map shows the geographic impact of Steven H. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven H. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven H. Olson more than expected).

Fields of papers citing papers by Steven H. Olson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven H. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven H. Olson. The network helps show where Steven H. Olson may publish in the future.

Co-authorship network of co-authors of Steven H. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Steven H. Olson. A scholar is included among the top collaborators of Steven H. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven H. Olson. Steven H. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foster, Nathan R., Asuka Inoue, Michael R. Jackson, et al.. (2025). Designing allosteric modulators to change GPCR G protein subtype selectivity. Nature. 648(8092). 229–238.
2.
Olson, Steven H., et al.. (2024). Structurally targeted mutagenesis identifies key residues supporting α-synuclein misfolding in multiple system atrophy. Journal of Parkinson s Disease. 14(8). 1543–1558. 3 indexed citations
3.
Feng, Yongmei, Stefan Grotegut, Predrag Jovanović, et al.. (2022). Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex. Frontiers in Pharmacology. 13. 1029093–1029093. 2 indexed citations
4.
Lee, Jisoo, Abby Oehler, Felicia K. Ooi, et al.. (2022). Multiple system atrophy prions transmit neurological disease to mice expressing wild-type human α-synuclein. Acta Neuropathologica. 144(4). 677–690. 16 indexed citations
5.
O’Brien, Connor, Steven H. Olson, Nicholas S. Settineri, et al.. (2021). Water-Soluble Iridium Photoredox Catalyst for the Trifluoromethylation of Biomolecule Substrates in Phosphate Buffered Saline Solvent. Organic Letters. 23(10). 3823–3827. 14 indexed citations
6.
Woerman, Amanda L., Smita S. Patel, Sabeen A. Kazmi, et al.. (2020). Kinetics of α-synuclein prions preceding neuropathological inclusions in multiple system atrophy. PLoS Pathogens. 16(2). e1008222–e1008222. 24 indexed citations
7.
Woerman, Amanda L., Abby Oehler, Sabeen A. Kazmi, et al.. (2019). Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines. Acta Neuropathologica. 137(3). 437–454. 63 indexed citations
8.
Woerman, Amanda L., Sabeen A. Kazmi, Smita S. Patel, et al.. (2017). MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathologica. 135(1). 49–63. 73 indexed citations
9.
Rauch, Jennifer N., Steven H. Olson, & Jason E. Gestwicki. (2016). Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules. Cold Spring Harbor Perspectives in Medicine. 7(7). a024034–a024034. 17 indexed citations
10.
Berry, David B., Carlo Condello, Brittany N. Dugger, et al.. (2016). Optimization of Aryl Amides that Extend Survival in Prion-Infected Mice. Journal of Pharmacology and Experimental Therapeutics. 358(3). 537–547. 25 indexed citations
11.
Canon, Jude, Tao Osgood, Steven H. Olson, et al.. (2015). The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents. Molecular Cancer Therapeutics. 14(3). 649–658. 116 indexed citations
12.
13.
Wang, Yingcai, Jieping Zhu, Jiwen Liu, et al.. (2014). Optimization beyond AMG 232: Discovery and SAR of sulfonamides on a piperidinone scaffold as potent inhibitors of the MDM2-p53 protein–protein interaction. Bioorganic & Medicinal Chemistry Letters. 24(16). 3782–3785. 13 indexed citations
14.
Beck, Hilary P., Brian M. Fox, John G. Allen, et al.. (2010). Improvement of the synthesis and pharmacokinetic properties of chromenotriazolopyrimidine MDM2-p53 protein-protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(9). 2752–2755. 29 indexed citations
15.
Olson, Steven H., Donald W. Graham, Gool F. Patel, et al.. (2008). Phenylcyclobutyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I. Bioorganic & Medicinal Chemistry Letters. 18(11). 3412–3416. 38 indexed citations
16.
Olson, Steven H., James M. Balkovec, Yunping Zhu, et al.. (2006). Attenuating pregnane X receptor (PXR) activation: A molecular modelling approach. Xenobiotica. 37(2). 124–138. 51 indexed citations
17.
Thieringer, Rolf, James M. Balkovec, Steven S. Mundt, et al.. (2004). A novel non-steroidal inhibitor of 11beta-hydroxysteroid dehydrogenase type 1 improves features of metabolic syndrome in murine disease models. 7. 6 indexed citations
18.
Toney, Jeffrey H., Gail G. Hammond, Paula M.D. Fitzgerald, et al.. (2001). Succinic Acids as Potent Inhibitors of Plasmid-borne IMP-1 Metallo-β-lactamase. Journal of Biological Chemistry. 276(34). 31913–31918. 171 indexed citations
19.
Farrar, Michael A., Steven H. Olson, & Roger M. Perlmutter. (2000). [31] Coumermycin-induced dimerization of GyrB-containing fusion proteins. Methods in enzymology on CD-ROM/Methods in enzymology. 327. 421–IN5. 21 indexed citations
20.
Toney, Jeffrey H., Paula M.D. Fitzgerald, Steven H. Olson, et al.. (1998). Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-β-lactamase. Chemistry & Biology. 5(4). 185–196. 206 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fengtian Xue Breakdown of academic impact, for papers by Stefania Girotto Breakdown of academic impact, for papers by Chul‐Hak Yang Breakdown of academic impact, for papers by Маргарита Е. Неганова Breakdown of academic impact, for papers by Yuepiao Cai Breakdown of academic impact, for papers by W. Stephen Faraci Breakdown of academic impact, for papers by Arie Gruzman Breakdown of academic impact, for papers by Gyan Modi Breakdown of academic impact, for papers by Wolfram Hänsel
Rankless by CCL
2026